title: Reply to "mTOR inhibitor-related pulmonary toxicity; incidence even higher".
authors.forename: Antonella
authors.initials: A
authors.lastname: Palazzo
authors.forename: Roberto
authors.initials: R
authors.lastname: Iacovelli
authors.forename: Enrico
authors.initials: E
authors.lastname: Cortesi
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008168:Lung / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy*; D011014:Pneumonia / Q000139:chemically induced*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D058570:TOR Serine-Threonine Kinases